查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1871198

精准营养穿戴式感测器市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

Precision Nutrition Wearable Sensors Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 190 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球精准营养穿戴式感测器市场价值为 28 亿美元，预计到 2034 年将以 12.5% 的复合年增长率成长至 94 亿美元。

精准营养穿戴式感测器市场 - IMG1

由于健康监测技术的进步和人们对个人化营养日益增长的兴趣，市场正在不断扩张。这些感测器能够即时追踪关键生理指标，例如水分含量、营养摄取量、代谢率和身体活动量。透过提供精准的监测，它们能够帮助消费者和医疗保健专业人员制定个人化的营养计划，改善健康状况，并预防与饮食相关的疾病。健康意识的提高、智慧型装置的普及以及生活方式相关疾病盛行率的上升，都催生了强劲的需求。新兴市场在可支配收入增加和对个人化健康解决方案的认知不断提高的推动下，展现出巨大的成长机会。多参数感测器、人工智慧驱动的分析以及与其他健康设备的整合等方面的创新，预计将加速市场成长。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 28亿美元
预测值 94亿美元
复合年增长率 12.5%

2024年，持续血糖监测（CGM）系统市占率达到45.1%，这反映了其在糖尿病管理和营养追踪领域数十年的临床验证。成熟的製造流程、感测器精度和完善的监管框架是该领域占据主导地位的重要因素。

代谢健康管理领域预计在2024年将占据50.2%的市场。此领域涵盖糖尿病、肥胖症和代谢症候群等疾病的监测和优化。市场对即时代谢资料的临床需求旺盛，这些数据有助于制定个人化干预措施、精准治疗方案、调整药物剂量，并预防代谢併发症的进展。

北美精准营养穿戴式感测器市场占据42.2%的市场份额，复合年增长率达12.6%，预计2024年美国市场规模将达到9.216亿美元。该地区的领先地位得益于先进的医疗基础设施、有利的监管环境以及健康技术的高普及率。美国食品药物管理局（FDA）针对穿戴式生物感测器所製定的清晰监管路径，在确保安全性和有效性的同时，也促进了创新。

全球精准营养穿戴式感测器市场的主要企业包括 Biolinq Inc.、Dexcom Inc.、雅培 (Abbott Laboratories)、Epicore Biosystems、美敦力 (Medtronic plc)、DayTwo Inc.、Nutrisense Inc.、Senseonics Holdings Inc.、Genesis Healthcare Co. 和 Prenetics Global Limited。这些企业专注于产品创新，整合人工智慧驱动的分析技术，并开发多参数感测器以提高准确性和易用性。与医疗服务提供者和研究机构建立策略合作伙伴关係，有助于进行临床验证并提升产品可信度。拓展分销管道和瞄准新兴市场有助于扩大全球影响力。企业重视合规性，以加速审批流程和市场推广。个人化解决方案、订阅式监测服务以及与行动应用程式的无缝设备集成，增强了客户参与度。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

  • 产业生态系分析
    • 供应商格局
    • 利润率
    • 每个阶段的价值增加
    • 影响价值链的因素
    • 中断
  • 产业影响因素
    • 成长驱动因素
    • 产业陷阱与挑战
    • 市场机会
  • 成长潜力分析
  • 监管环境
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特的分析
  • PESTEL 分析
  • 价格趋势
    • 按地区
    • 按产品类别
  • 未来市场趋势
  • 技术与创新格局
    • 当前技术趋势
    • 新兴技术
  • 专利格局
  • 贸易统计（HS编码说明：仅提供重点国家的贸易统计）
    • 主要进口国
    • 主要出口国
  • 永续性和环境方面
    • 永续实践
    • 减少废弃物策略
    • 生产中的能源效率
    • 环保倡议
  • 碳足迹考量

第四章：竞争格局

  • 介绍
  • 公司市占率分析
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • MEA
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 关键进展
    • 併购
    • 合作伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场估算与预测：依技术类型划分，2021-2034年

  • 主要趋势
  • 持续血糖监测仪（CGM）
  • 基于汗液的生物感测器
  • 生物阻抗感测器
  • 光学感测器

第六章：市场估算与预测：依应用领域划分，2021-2034年

  • 主要趋势
  • 代谢健康管理
    • 血糖监测与糖尿病管理
    • 酮症追踪应用程式
    • 代谢灵活性评估
  • 运动营养与运动表现
    • 水合用监测系统
    • 电解质平衡追踪
    • 乳酸测定
  • 临床营养治疗
    • 疾病管理应用
    • 治疗监测系统
    • 药物依从性追踪
  • 一般健康与预防
    • 生活方式优化平台
    • 膳食依从性监测
    • 预防保健应用

第七章：市场估算与预测：依最终用途划分，2021-2034年

  • 主要趋势
  • 医疗保健提供者
    • 医院整合系统
    • 诊所监测计划
    • 远距医疗平台集成
  • 直接面向消费者
    • 个人消费者采用
    • 健身爱好者群
    • 注重健康的使用者群体
  • 企业健康计划
    • 雇主赞助的健康计划
    • 保险公司合作关係
    • 职业健康应用
  • 研究机构
    • 临床试验申请
    • 学术研究项目
    • 药物开发支持

第八章：市场估算与预测：依地区划分，2021-2034年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第九章：公司简介

  • Abbott Laboratories
  • Biolinq Inc
  • DayTwo Inc
  • Dexcom Inc
  • Epicore Biosystems
  • Genesis Healthcare Co.
  • Medtronic plc
  • Nutrisense Inc
  • Prenetics Global Limited
  • Senseonics Holdings Inc
简介目录
Product Code: 15022

The Global Precision Nutrition Wearable Sensors Market was valued at USD 2.8 Billion in 2024 and is estimated to grow at a CAGR of 12.5% to reach USD 9.4 Billion by 2034.

Precision Nutrition Wearable Sensors Market - IMG1

The market is expanding due to advancements in health-monitoring technologies and growing interest in personalized nutrition. These sensors provide real-time tracking of key physiological metrics such as hydration, nutrient intake, metabolic rate, and physical activity. By offering accurate monitoring, they enable both consumers and healthcare professionals to tailor nutrition plans, enhance health outcomes, and prevent diet-related conditions. The rising health awareness, proliferation of smart devices, and increasing prevalence of lifestyle-related diseases are creating strong demand. Emerging markets are presenting significant growth opportunities, driven by higher disposable incomes and growing awareness of personalized health solutions. Innovations in multi-parameter sensors, AI-driven analytics, and integration with other health devices are expected to accelerate market growth.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$2.8 Billion
Forecast Value$9.4 Billion
CAGR12.5%

The continuous glucose monitoring (CGM) systems segment held a 45.1% share in 2024, reflecting decades of clinical validation in managing diabetes and nutritional tracking. The maturity of manufacturing, sensor accuracy, and established regulatory frameworks contribute to the segment's dominance.

The metabolic health management segment held a 50.2% share in 2024. This includes monitoring and optimizing conditions such as diabetes, obesity, and metabolic syndrome. The high demand stems from the clinical need for real-time metabolic data, which supports personalized interventions, helps in precise therapy prescriptions, adjusts medication dosages, and prevents the progression of metabolic complications.

North America Precision Nutrition Wearable Sensors Market captured 42.2% share, with a CAGR of 12.6%, and the U.S. market was valued at USD 921.6 million in 2024. The region's leadership is supported by advanced healthcare infrastructure, a favorable regulatory environment, and high adoption of health technologies. The FDA's clear regulatory pathways for wearable biosensors reinforce innovation while ensuring safety and efficacy.

Leading companies in the Global Precision Nutrition Wearable Sensors Market include Biolinq Inc., Dexcom Inc., Abbott Laboratories, Epicore Biosystems, Medtronic plc, DayTwo Inc., Nutrisense Inc., Senseonics Holdings Inc., Genesis Healthcare Co., and Prenetics Global Limited. Companies in the Precision Nutrition Wearable Sensors Market focus on product innovation, integrating AI-powered analytics, and developing multi-parameter sensors to improve accuracy and usability. Strategic partnerships with healthcare providers and research institutions enable clinical validation and credibility. Expanding distribution channels and targeting emerging markets help increase global reach. Companies emphasize regulatory compliance to speed up approvals and market adoption. Personalized solutions, subscription-based monitoring services, and seamless device integration with mobile apps strengthen customer engagement.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Technology type
    • 2.2.3 Application
    • 2.2.4 End Use
  • 2.3 TAM Analysis, 2025-2034
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By product category
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (HS code Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives
  • 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Technology Type, 2021-2034 (USD Million & Units)

  • 5.1 Key trends
  • 5.2 Continuous glucose monitors (CGMs)
  • 5.3 Sweat-based biosensors
  • 5.4 Bioimpedance sensors
  • 5.5 Optical sensors

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 (USD Million & Units)

  • 6.1 Key trends
  • 6.2 Metabolic health management
    • 6.2.1 Glucose monitoring & diabetes management
    • 6.2.2 Ketosis tracking applications
    • 6.2.3 Metabolic flexibility assessment
  • 6.3 Sports nutrition & performance
    • 6.3.1 Hydration monitoring systems
    • 6.3.2 Electrolyte balance tracking
    • 6.3.3 Lactate measurement
  • 6.4 Clinical nutrition therapy
    • 6.4.1 Disease management applications
    • 6.4.2 Therapeutic monitoring systems
    • 6.4.3 Medication adherence tracking
  • 6.5 General wellness & prevention
    • 6.5.1 Lifestyle optimization platforms
    • 6.5.2 Dietary compliance monitoring
    • 6.5.3 Preventive health applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021-2034 (USD Million & Units)

  • 7.1 Key trends
  • 7.2 Healthcare providers
    • 7.2.1 Hospital integration systems
    • 7.2.2 Clinic-based monitoring programs
    • 7.2.3 Telehealth platform integration
  • 7.3 Direct-to-consumer
    • 7.3.1 Individual consumer adoption
    • 7.3.2 Fitness enthusiast segment
    • 7.3.3 Health-conscious user demographics
  • 7.4 Corporate wellness programs
    • 7.4.1 Employer-sponsored health initiatives
    • 7.4.2 Insurance company partnerships
    • 7.4.3 Occupational health applications
  • 7.5 Research institutions
    • 7.5.1 Clinical trial applications
    • 7.5.2 Academic research programs
    • 7.5.3 Pharmaceutical development support

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 (USD Million & Units)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Biolinq Inc
  • 9.3 DayTwo Inc
  • 9.4 Dexcom Inc
  • 9.5 Epicore Biosystems
  • 9.6 Genesis Healthcare Co.
  • 9.7 Medtronic plc
  • 9.8 Nutrisense Inc
  • 9.9 Prenetics Global Limited
  • 9.10 Senseonics Holdings Inc